Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Vitespen||Oncophage|HSPPC-96||Oncophage (vitespen) is a cancer vaccine that uses gp96 as an antigen, which may induce immune response against tumor cells expressing gp96 (PMID: 11727524).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT02452281||Phase Ib/II||Vitespen Ipilimumab||Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma||Withdrawn|